Evaluation of Woulgan in Diabetic Foot Ulcer

PHASE4CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

April 30, 2019

Conditions
Diabetic Foot Ulcers
Interventions
DEVICE

Woulgan Gel

Primary dressing gel to be applied to the wound bed, and to be covered with a secondary bandage.

DEVICE

Intrasite Hydrogel

Primary dressing hydrogel to be applied to the wound bed, and to be covered with a secondary bandage

Trial Locations (3)

S-22185

Skaane University Hospital, Lund

N18 1QX

North Middlesex University Hospital, London

NG72UH

Nottingham University Hospital, Nottingham

Sponsors
All Listed Sponsors
lead

Biotec Pharmacon ASA

INDUSTRY